Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines

The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidence...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Critical reviews in oncology/hematology 2020-02, Vol.146, p.102858-102858, Article 102858
Hauptverfasser:	Passiglia, F., Pilotto, S., Facchinetti, F., Bertolaccini, L., Del Re, M., Ferrara, R., Franchina, T., Malapelle, U., Menis, J., Passaro, A., Ramella, S., Rossi, G., Trisolini, R., Novello, S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - therapeutic use Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - pathology Clinical practice guidelines Humans Italy Lung Neoplasms - drug therapy Lung Neoplasms - pathology Medical Oncology - standards Metastatic disease Non-small cell lung cancer Practice Guidelines as Topic Recommendations Societies, Medical
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.
ISSN:	1040-8428 1879-0461
DOI:	10.1016/j.critrevonc.2019.102858